(Q53671035)

17 May 2018

editorial

0 references

title

Intravitreous bevacizumab adult safety data: the evidence so far. (English)

1 reference

17 May 2018

1 reference

Salmaan Al-Qureshi

1

1 reference

17 May 2018

Saad Shaikh

series ordinal

2

1 reference

17 May 2018

publication date

1 January 2012

1 reference

17 May 2018

Clinical and Experimental Ophthalmology

published in

1 reference

17 May 2018

volume

40

1 reference

17 May 2018

issue

1

1 reference

17 May 2018

page(s)

3-5

1 reference

17 May 2018

Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02739.X

Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02739.X

The effect of methotrexate on corneal neovascularization in rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02739.X

Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02739.X

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02739.X

Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02739.X

10.1111/J.1442-9071.2011.02739.X

21 January 2018

Identifiers

DOI

1 reference

17 May 2018

1 reference

17 May 2018